Beroni Group Competitors and Similar CompaniesClear all
Beroni Group's competitors and similar companies include Clovis Oncology, ARIAD Pharmaceuticals, Aura Biosciences and Accent Therapeutics.
 Clovis Oncology Clovis Oncology is a biopharmaceutical company focused on acquiring, developing and commercializing anti-cancer agents. |  ARIAD Pharmaceuticals ARIAD Pharmaceuticals is a global oncology company focused on discovering, developing and commercializing precision therapies for patients with rare cancers. |  Aura Biosciences Aura Biosciences is a clinical-stage biotechnology company that designs an oncology platform for the delivery of drugs targeting cancer indications, focusing on ocular and urologic oncology. |  Accent Therapeutics Accent Therapeutics is a biopharmaceutical company engaged in the development of therapies for cancer. | ||
Founding Date | Founding Date 2014 | Founding Date 2009 | Founding Date 1991 | Founding Date 2009 | Founding Date 2017 |
Type | Type Public | Type Public | Type Subsidiary | Type Public | Type Private |
Tags | |||||
Locations | Locations Sydney, AU HQ Kensington, AU Chuo City, JP Shinjuku City, JP Fort Lee, US | Locations Cambridge, US HQ Boston, US Chicago, US Cincinnati, US Dallas, US Minneapolis, US New York, US see more | Locations Cambridge, US HQ | Locations Lexington, US HQ | |
Employees | Employees N/A | Employees 4843% increase | Employees 1381% increase | Employees 42 | Employees 353% increase |
Valuation ($) | Valuation ($) 192.9 m | Valuation ($) 10.6 m | Valuation ($) N/A | Valuation ($) 544.2 m | Valuation ($) N/A |
Financial | |||||
Revenue (est.) | Revenue (est.) $638k (FY, 2025) | Revenue (est.) $148.8m (FY, 2021) | Revenue (est.) $118.8m (FY, 2015) | Revenue (est.) N/A | Revenue (est.) N/A |
Cost of goods | Cost of goods $159k (FY, 2025) | Cost of goods N/A | Cost of goods $2.1m (FY, 2015) | Cost of goods N/A | Cost of goods N/A |
Gross profit | Gross profit $562k (FY, 2025) | Gross profit N/A | Gross profit $116.7m (FY, 2015) | Gross profit N/A | Gross profit N/A |
Net income | Net income ($4.5m) (FY, 2025) | Net income ($264.5m) (FY, 2021) | Net income ($231.2m) (FY, 2015) | Net income ($106.2m) (FY, 2025) | Net income N/A |
Funding | |||||
Total funding raised | Total funding raised N/A | Total funding raised $ 357m | Total funding raised N/A | Total funding raised $ 213.9m | Total funding raised $ 103m |
For sources of this data, please see the company profile
View Company Profiles
Clovis Oncology
HQ
Boulder, US
Employees
484↑ 3% increase
Clovis Oncology is a biopharmaceutical company focused on acquiring, developing and commercializing anti-cancer agents.
View companyARIAD Pharmaceuticals
HQ
Cambridge, US
ARIAD Pharmaceuticals is a global oncology company focused on discovering, developing and commercializing precision therapies for patients with rare cancers.
View companyAura Biosciences
HQ
Cambridge, US
Employees
42
Aura Biosciences is a clinical-stage biotechnology company that designs an oncology platform for the delivery of drugs targeting cancer indications, focusing on ocular and urologic oncology.
View companyAccent Therapeutics
HQ
Lexington, US
Employees
35↑ 3% increase
Accent Therapeutics is a biopharmaceutical company engaged in the development of therapies for cancer.
View company